There are 2867 resources available
LBA9 - Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)
Presenter: Chris Parker
Session: Presidential Symposium III
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA45 and 887O
Presenter: Jonathan Strosberg
Session: Proffered Paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
Late haematological malignancies of systemic anticancer therapies
Presenter: Jean Baptiste Micol
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
1320MO - New oncologic drugs since 2010: Differences in approval and access between the United States, Europe and Brazil
Presenter: Rafael Barreto
Session: Mini Oral session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Invited Discussant 455MO and 466MO
Presenter: Ulrik Lassen
Session: Mini Oral session: Developmental therapeutics
Resources:
Slides
Webcast
Invited Discussant LBA9
Presenter: Silke Gillessen
Session: Presidential Symposium III
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: NETs and endocrine tumours
Resources:
Slides
Webcast
Chronic toxicities of targeted therapies and their implication on compliance: Illustration with new endocrine therapies and CDK4 inhibitors
Presenter: Erica Mayer
Session: Emerging toxicities of new anticancer therapies
Resources:
Slides
Webcast
457MO - A phase I study of ATR inhibitor M1774 in patients with solid tumours (DDRiver Solid Tumours 301): Part A1 results
Presenter: Timothy Yap
Session: Mini Oral session: Developmental therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant 1317MO, 1319MO and 1320MO
Presenter: Daniel Goldstein
Session: Mini Oral session: Policy and preventive strategies
Resources:
Slides
Webcast